ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 614495 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 614495; 2) Community: the network communities that were significantly associated with the response to NSC 614495; 3) Molecule: the relationships between components within communities and NSC 614495; 4) MDR: the compounds that were significantly associated with the NSC 614495.

NSC Compound Enrichment Correlation
NSC 734872 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.00306027196853062 0.37323639
NSC 750285 DP1 0.00306027196853062 0.21086915
NSC 751295 diaporthein B 0.00306027196853062 0.09743843
NSC 758664 Sirolimus [USAN] 0.00347157511980527 -0.083656272
NSC 308847 Amonafide 0.00347157511980532 0.34432547
NSC 357704 Cyanomorpholinodoxorubicin 0.00404192617431249 0.27850519
NSC 606985 Camptothecin Derivative 0.00404192617431249 0.37482823
NSC 658103 Null 0.00404192617431249 0.46407352
NSC 660636 2-[1-(4-(4'-acetophenone)piperazino)]-naphthazarin 0.00404192617431249 0.35814979
NSC 683558 Camptothecin Derivative 0.00404192617431249 0.25915801
Total:53  Current:5    [First] [Prev] [Next] [Last]